Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period (original) (raw)
References
Schrappe M, Camitta B, Pui CH on behalf of Eden T, Gaynon P, Gustafsson G, Janka-Schaub GE, Kamps W, Masera G, Sallan S, Tsuchida M, Vilmer E . Long-term results of large prospective trials in childhood acute lymphoblastic leukemia Leukemia 2000 14: 2193–2194 ArticleCAS Google Scholar
Dekker AW, van't Veer MB, Sizoo W, Haak HL, van der Lelie J, Ossenkoppele G, Huijgens PC, Schouten HC, Sonneveld P, Willemze R, Verdonck LF, van Putten WL, Löwenberg B . Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group J Clin Oncol 1997 15: 476–482 ArticleCAS Google Scholar
Durrant IJ, Prentice HG, Richards SM . Intensification of treatment for adults with acute lymphoblastic leukaemia: results of UK Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults Br J Haematol 1997 99: 84–92 ArticleCAS Google Scholar
Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, Varet B, Broustet A, Cahn JY, Rigal-Huguet F, Witz F, Michaux JL, Michallet M, Reiffers J . Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy J Clin Oncol 1993 11: 1990–2001 ArticleCAS Google Scholar
Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt FC, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken C, Hellriegel KP, Spors S, Nowrousian RM, Fischer J, Frülle H, Mitrou PS, Pfreundschuh M, Görg C, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T . Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults Blood 1984 64: 38–47 CASPubMed Google Scholar
Hoelzer D, Thiel E, Ludwig WD, Löffler H, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B, Gökbuget N, Aydemir U, for the German Adult ALL Study Group . Follow-up of the first two successive German multicentre trials for adult ALL (O1/81 and 02/84) Leukemia 1993 7 (Suppl. 2): S130–S134 Google Scholar
Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA . A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811 Blood 1995 85: 2025–2037 CASPubMed Google Scholar
Mandelli F, Annino L, Rotoli B for the GIMEMA Cooperative Group . The GIMEMA ALL 0183 trial, analysis of 10-year follow-up Br J Haematol 1996 92: 663–672 Article Google Scholar
Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ . Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia J Clin Oncol 2000 18: 547–561 ArticleCAS Google Scholar
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposals for the classification of acute leukaemias Br J Haematol 1976 33: 451–458 ArticleCAS Google Scholar
Boucheix C, David B, Sebban C, Racadot E, Bené MC, Bernard A, Campos L, Jouault H, Sigaux F, Lepage E, Hervé P, Fiere D for the French Group on Therapy for Adult Acute Lymphoblastic Leukemia . Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87) Blood 1994 84: 1603–1612 CASPubMed Google Scholar
ISCN (International System for Human Cytogenetic Nomenclature) . Guidelines for Cancer Cytogenetics. In: Mitelman F (ed) Supplement to an International System for Human Cytogenetic Nomenclature Karger: Basel 1991 1–53 Google Scholar
Cortes J, O'Brien SM, Pierce S, Keating MJ, Freireich EJ, Kantarjian HM . The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia Blood 1995 86: 2091–2097 CASPubMed Google Scholar
Fiere D, Marty M, Solal-Celigny P, Harousseau JL, Gorin NC, Desablens B, Brière J, David B, Bordessoule D, Hayat M, Tanzer J, Maupas J . Induction massive et consolidation précoce des leucémies aiguës lymphoïdes de l'adulte. Etude pilote de faisabilité et évolution lointaine La Presse Médicale 1989 18: 221–223 CASPubMed Google Scholar
Fiere D, Archimbaud E, Extra JM, Marty M, David B, Witz F, Sotto JJ, Rochant H, Gastaut JA, Le Prise PY . Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group. In: Büchner T et al (eds) Acute Leukemias. Prognostic Factors and Treatment Strategies Springer-Verlag: Berlin 1987 pp 125–129 Google Scholar
Thomas X, Danaïla C, Bach QK, Dufour P, Christian B, Corront B, Bosly A, Bastion Y, Gratecos N, Leblay R, Sebban C, Archimbaud E, Fiere D . Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia Ann Hematol 1995 70: 65–69 ArticleCAS Google Scholar
Delannoy A, Cazin B, Thomas X, Marit G, Huguet F, Bouabdallah R, Rossanino S, Nedellec G, Renoux M, Voillat L, Reman O, Turlure P, Lefrère F, Sebban C, Lhéritier V, Fiere D . Preliminary results of an age-adapted protocol in elderly patients with acute lymphocytic leukemia (ALL) Blood 1999 94 (Suppl. 1): 227b Google Scholar
Dombret H, Thomas X, Blaise D, Huguet F, Boiron JM, Buzyn A, Stamatoulas A, Delannoy A, Bradstock K, Boucheix C, Charrin C, Gabert J, Lebbé G, Lhéritier V, Fiere, D . Intensive therapy in 100 patients with Ph1 and/or BCR/ABL positive acute lymphoblastic leukemia (ALL): First interim analysis of the French–Belgian–Australian LALA-94 trial Br J Haematol 1998 102: 270 Article Google Scholar
Delannoy A, Sebban C, Cony-Makhoul P, Cazin B, Cordonnier C, Bouabdallah R, Cahn JY, Dreyfus F, Sadoun A, Vernant JP, Gay C, Broustet A, Michaux JL, Fiere D for the French Group for Treatment of Adult Acute Lymphoblastic Leukemia . Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients Leukemia 1997 11: 1429–1434 ArticleCAS Google Scholar
Schauer P, Arlin ZA, Mietelsmann R, Corrincione C, Friedman A, Gee TS, Dowling M, Kempin S, Straus DT, Koziner B, McKenzie S, Thaler HT, Dufour P, Little C, Dellaquila C . Treatment of acute lymphoblastic leukemia in adults: Results of the L-10 and L-10M protocols J Clin Oncol 1983 1: 462–470 ArticleCAS Google Scholar
Stryckmans PA, Otten J, Delbeke MJ, Suciu S, Fiere D, Bury J, Solbu G, Benoit Y for the EORTC Hemopathies Working Party . Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults Blood 1983 62: 606–615 CASPubMed Google Scholar
Coiffier B, Bryon PA, Ffrench M, Blanc M, Sebban C, Berger F, Viala JJ . Intensive chemotherapy in aggressive lymphomas: updated results of LNH-80 protocol and prognostic factors affecting response and survival Blood 1987 70: 1394–1399 CASPubMed Google Scholar
Patte C, Michon J, Frappaz D, Leverger G, Rubie H, Soussain C, Pico JL . Therapy of Burkitt and other B cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults Baillière's Clin Haematol 1994 7: 339–348 ArticleCAS Google Scholar
Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, Sawitsky A, Rosner F, Gussoff B, Silver RT, Karanas A, Cuttner J, Spurr CL, Hayes DM, Bloom J, Leone LA, Haurani F, Kyle R, Hutchison JL, Forcier RJ, Moon JH . Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults Blood 1968 32: 507–523 CASPubMed Google Scholar
Kaplan EL, Meier P . Nonparametric estimation form in complete observations J Am Stat Assoc 1958 53: 457–481 Article Google Scholar
Cox DR . Regression models and life tables JR Stat Soc B 1972 34: 187–220 Google Scholar
Linker CA, Levitt LJ, O'Donnell M, Forman SJ, Ries CA . Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report Blood 1991 78: 2814–2822 CASPubMed Google Scholar
Hussein KK, Dahlberg S, Head D, Waddell CC, Dabich LK, Weick JK, Morrison F, Saiki JH, Metz E, Rivkin SE, Grever MR, Boldt D and the Southwest Oncology Group . Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy Blood 1989 73: 57–63 CASPubMed Google Scholar
Kantarjian HM, Walters RS, Keating MJ, Smith TL, O'Brien S, Estey EH, Huh YO, Spinolo J, Dicke K, Barlogie B, McCredie KB, Freireich EJ . Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard and high-risk acute lymphocytic leukemia J Clin Oncol 1990 8: 994–1004 ArticleCAS Google Scholar
Zang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Loffler H, Sobocinski KA, Thiel E, Weisdorf DJ . Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Commitee Ann Intern Med 1995 123: 428–431 Article Google Scholar
Thomas X, Olteanu N, Charrin C, Lhéritier V, Magaud JP, Fiere D . Acute lymphoblastic leukemia in the elderly: the Edouard Herriot Hospital experience Am J Hematol 2001 67: 73–83 ArticleCAS Google Scholar
Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Koch P, Freund M, Dietrich H, Rühl H, Maschmeyer G, Lipp T, Nowrousian RM, Burkert M, Gerecke D, Pralle H, Mûller U, Lunscken C, Frülle H, Ho AD, Küchler R, Busch FW, Schneider W, Görg C, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D . Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults Blood 1988 71: 123–131 CASPubMed Google Scholar
Groupe Français de Cytogénétique Hématologique . Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique Blood 1996 87: 3135–3142 Google Scholar
Parker SL, Tong T, Bolden S, Wingo PA . Cancer statistics, 1997 Cancer J Clin 1997 47: 5–27 ArticleCAS Google Scholar
Simon R . Importance of prognostic factors in cancer clinical trials Cancer Treat Rep 1984 68: 185–192 CASPubMed Google Scholar
Thomas X, Thiebaut A, Olteanu N, Danaïla C, Charrin C, Archimbaud E, Fiere D . Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome Hematol Cell Ther 1998 40: 119–128 CASPubMed Google Scholar
Sebban C, Lepage E, Vernant JP, Gluckman E, Attal M, Reiffers J, Sutton L, Racadot E, Michallet M, Maraninchi D, Dreyfus F, Fiere D for the French Group of Therapy of Adult Acute Lymphoblastic Leukemia . Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study J Clin Oncol 1994 12: 2580–2587 ArticleCAS Google Scholar
Thiebaut A, Vernant JP, Degos L, Rigal-Huguet F, Reiffers J, Sebban C, Lepage E, Thomas X, Fiere D . Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87 Hematol Oncol Clin North Am 2000 14: 1353–1365 ArticleCAS Google Scholar
Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, Weisenburger DD, Kessinger A, Armitage JO . Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell for lymphoid malignancies J Clin Oncol 1994 12: 2527–2534 ArticleCAS Google Scholar